136 related articles for article (PubMed ID: 9107663)
1. Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging.
Keogan MT; Lowe VJ; Baker ME; McDermott VG; Lyerly HK; Coleman RE
Abdom Imaging; 1997; 22(3):332-7. PubMed ID: 9107663
[TBL] [Abstract][Full Text] [Related]
2. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
[TBL] [Abstract][Full Text] [Related]
3. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection.
Even-Sapir E; Parag Y; Lerman H; Gutman M; Levine C; Rabau M; Figer A; Metser U
Radiology; 2004 Sep; 232(3):815-22. PubMed ID: 15273334
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
[TBL] [Abstract][Full Text] [Related]
6. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
Patz EF; Lowe VJ; Hoffman JM; Paine SS; Harris LK; Goodman PC
Radiology; 1994 May; 191(2):379-82. PubMed ID: 8153309
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
[TBL] [Abstract][Full Text] [Related]
8. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
Patz EF; Lowe VJ; Hoffman JM; Paine SS; Burrowes P; Coleman RE; Goodman PC
Radiology; 1993 Aug; 188(2):487-90. PubMed ID: 8327702
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.
Lapela M; Grénman R; Kurki T; Joensuu H; Leskinen S; Lindholm P; Haaparanta M; Ruotsalainen U; Minn H
Radiology; 1995 Oct; 197(1):205-11. PubMed ID: 7568825
[TBL] [Abstract][Full Text] [Related]
10. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients.
Moore HG; Akhurst T; Larson SM; Minsky BD; Mazumdar M; Guillem JG
J Am Coll Surg; 2003 Jul; 197(1):22-8. PubMed ID: 12831920
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
Erasmus JJ; Patz EF; McAdams HP; Murray JG; Herndon J; Coleman RE; Goodman PC
AJR Am J Roentgenol; 1997 May; 168(5):1357-60. PubMed ID: 9129444
[TBL] [Abstract][Full Text] [Related]
12. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data.
Smeets P; Ham H; Ceelen W; Boterberg T; Verstraete K; Goethals I
Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):327-32. PubMed ID: 20639817
[TBL] [Abstract][Full Text] [Related]
14. Detecting recurrent or residual lung cancer with FDG-PET.
Inoue T; Kim EE; Komaki R; Wong FC; Bassa P; Wong WH; Yang DJ; Endo K; Podoloff DA
J Nucl Med; 1995 May; 36(5):788-93. PubMed ID: 7738649
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT in the detection of recurrent rectal cancer.
Kau T; Reinprecht P; Eicher W; Lind P; Starlinger M; Hausegger KA
Int Surg; 2009; 94(4):315-24. PubMed ID: 20302028
[TBL] [Abstract][Full Text] [Related]
16. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
[TBL] [Abstract][Full Text] [Related]
17. [The value of positron emission tomography in the diagnosis of recurrent rectal cancer].
Lehner B; Schlag P; Strauss L; Dimitrakopoulou A; Herfarth C
Zentralbl Chir; 1990; 115(13):813-7. PubMed ID: 2238957
[TBL] [Abstract][Full Text] [Related]
18. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
Metser U; You J; McSweeney S; Freeman M; Hendler A
AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157
[TBL] [Abstract][Full Text] [Related]
19. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity.
Ito K; Kato T; Ohta T; Tadokoro M; Yamada T; Ikeda M; Nishino M; Ishigaki T; Gambhir S
Eur J Nucl Med; 1996 Oct; 23(10):1372-7. PubMed ID: 8781143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
